Benzene and substituted derivatives
2,4,5-Trifluorophenylacetic Acid 98.0+%, TCI America™
CAS: 209995-38-0 Molecular Formula: C8H5F3O2 Molecular Weight (g/mol): 190.12 MDL Number: MFCD00082479 InChI Key: YSQLGGQUQDTBSL-UHFFFAOYSA-N Synonym: 2,4,5-trifluorophenylacetic acid,2-2,4,5-trifluorophenyl acetic acid,2,4,5-trifluorophenyl acetic acid,2,4,5-trifluoro-phenyl-acetic acid,2,4,5-trifluorophenylaceticacid,2,4,5-trifluoro phenyl acetic acid,benzeneacetic acid, 2,4,5-trifluoro,pubchem3526,pubchem7287 PubChem CID: 2777950 IUPAC Name: 2-(2,4,5-trifluorophenyl)acetic acid SMILES: OC(=O)CC1=CC(F)=C(F)C=C1F
5-Iodo-o-toluic Acid 98.0+%, TCI America™
CAS: 54811-38-0 Molecular Formula: C8H7IO2 Molecular Weight (g/mol): 262.046 MDL Number: MFCD01570258 InChI Key: WUBHOZQZSHGUFI-UHFFFAOYSA-N Synonym: 5-Iodo-2-methylbenzoic Acid PubChem CID: 621745 IUPAC Name: 5-iodo-2-methylbenzoic acid SMILES: CC1=C(C=C(C=C1)I)C(=O)O
eMolecules Laurophenone | 1674-38-0 | MFCD00008967 | 25g
Combi-Blocks | Laurophenone | 25g | 267172321 | QB-3501 | 95.000 | 1674-38-0 | MFCD00008967 | 260.421 | C18H28O
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC TSTU | 105832-38-0 | MFCD00077875 | ≥99.0% | 301.05 | 50 G
TSTU is a coupling reagent used in peptide chemistry. It converts carboxylic acids into N-hydroxysuccinimidyl (NHS) esters and can be applied to attach labels to peptides, proteins, and similar molecules. It is also suitable for the in situ formation of succinimide esters in mixed aqueous/organic media for amide bond formation reactions.
- Converts carboxylic acids into N-hydroxysuccinimidyl (NHS) esters.
- Suitable for attaching labels to peptides and proteins.
- Applied for in situ formation of succinimide esters.
- Used in amide bond formation reactions.
Medchemexpress LLC S-(4-Hydroxybenzyl)glutathione | 129636-38-0 | 5 MG
S-(4-Hydroxybenzyl)glutathione is a glutathione derivative that inhibits the in vitro binding of kainic acid to brain glutamate receptors, with an IC50 of 2 μM. It is intended for research use only.
- Glutathione derivative
- Inhibits kainic acid binding to brain glutamate receptors
- IC50 of 2 μM
- Molecular weight: 413.45
- Molecular formula: C17H23N3O7S
- Appearance: White to off-white solid
- Isolated from plants, Orchidaceae, Gastrodia elata Bl.
Medchemexpress LLC S-(4-Hydroxybenzyl)glutathione | 129636-38-0 | 10 MG
S-(4-Hydroxybenzyl)glutathione is a glutathione derivative. It has been shown to inhibit the in vitro binding of kainic acid to brain glutamate receptors, with an IC50 of 2 μM.
- It is a glutathione derivative.
- It inhibits the in vitro binding of kainic acid to brain glutamate receptors.
- It has an IC50 of 2 μM for inhibiting kainic acid binding.
eMolecules 2-(4-FLUOROPHENYL)THIOMORPHOLINE | 1001940-38-0 | MFCD03002056 | 1g
AstaTech | 2-(4-FLUOROPHENYL)THIOMORPHOLINE | 1g | 112532609 | AR3917 | 95.000 | 1001940-38-0 | MFCD03002056 | 197.270 | C10H12FNS
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Chenodeoxycholic acid sodium | 2646-38-0 | 98.6% | C24H39NaO4 | 5 G
Chenodeoxycholic acid sodium is a hydrophobic primary bile acid that activates nuclear receptors (FXR) involved in cholesterol metabolism. This product is intended for research use only.
- Molecular weight: 414.55
- Appearance: Solid
- Color: White to off-white
- Structure classification: Steroids
- Initial source: Endogenous metabolite
- Solubility in DMSO: 100 mg/mL (241.23 mM); requires ultrasonic, use newly opened DMSO due to hygroscopic nature
- Solubility in H2O: 8.75 mg/mL (21.11 mM); requires ultrasonic and warming to 60°C
Medchemexpress LLC Chenodeoxycholic acid sodium | 2646-38-0 | 98.6% | C24H39NaO4 | 500 MG
Chenodeoxycholic acid sodium is a hydrophobic primary bile acid that activates nuclear receptors (FXR) involved in cholesterol metabolism. It is for research use only.
- Activates nuclear receptors (FXR)
- Involved in cholesterol metabolism
- Hydrophobic primary bile acid
- Solid, white to off-white appearance
- Classified as a steroid
- Endogenous metabolite
Medchemexpress LLC Chenodeoxycholic acid sodium | 2646-38-0 | 98.61% | C24H39NaO4 | 100 MG
Chenodeoxycholic acid sodium is a hydrophobic primary bile acid that activates nuclear receptors (FXR) involved in cholesterol metabolism. It is for research use only.
- Activates nuclear receptors (FXR)
- Inhibits 11 beta HSD2
- Stimulates Ishikawa cell growth
- Induces LDL receptor mRNA levels
- Activates C/EBPβ
- Activates AMP-activated protein kinase (AMPK)
Medchemexpress LLC Chenodeoxycholic acid sodium | 2646-38-0 | 98.6% | C24H39NaO4 | 1 G
Chenodeoxycholic acid sodium is a hydrophobic primary bile acid that activates nuclear receptors (FXR) involved in cholesterol metabolism. It inhibits 11 beta HSD2 with an IC50 of 22 mM and causes cortisol-dependent nuclear translocation, increasing transcriptional activity of the mineralocorticoid receptor (MR). This compound is for research use only.
- Inhibits 11 beta HSD2.
- Increases MR transcriptional activity.
- Stimulates Ishikawa cell growth via Cyclin D1 protein and mRNA expression.
- Activates TGR5-dependent pathway.
- Induces LDL receptor mRNA levels in Hep G2 cells.
- Increases HMG-CoA reductase and synthase mRNA levels.
- Activates C/EBPβ, enhancing luciferase gene transcription.
- Activates AMPK, leading to ERK1/2 activation.
Medchemexpress LLC 4-Phenoxyphenylboronic acid | 51067-38-0 | 99.98% | C12H11BO3 | 25 G
4-Phenoxyphenylboronic acid is a biochemical reagent used in various life science related research applications.
- Biochemical reagent for research
- Suitable as a biological material or organic compound
- Can be used as a reactant in in vitro studies
Medchemexpress LLC 4-Bromo-3-hydroxybenzoic acid | 14348-38-0 | 217.018 | 1 G
4-Bromo-3-hydroxybenzoic acid is a metabolite of Brocresine and a histidine decarboxylase (HDC) inhibitor, with an IC50 of 1 mM for both rat fetal and rat gastric HDC. It also inhibits aromatic-L-amino acid decarboxylase from hog kidney and rat gastric mucosa in vitro. This product is intended for research use only.
- Acts as a histidine decarboxylase inhibitor
- Inhibits aromatic-L-amino acid decarboxylase
- Suitable for in vitro research applications
- Solid appearance, white to off-white color
Medchemexpress LLC 4-Bromo-3-hydroxybenzoic acid | 14348-38-0 | 217.018 | 10 G
4-Bromo-3-hydroxybenzoic acid is a metabolite of Brocresine. It functions as an inhibitor of histidine decarboxylase (HDC), demonstrating an IC50 of 1 mM for both rat fetal and rat gastric HDC. Additionally, it inhibits aromatic-L-amino acid decarboxylase from hog kidney and rat gastric mucosa in vitro.
- Functions as a histidine decarboxylase (HDC) inhibitor
- Inhibits aromatic-L-amino acid decarboxylase
- Identified as a Brocresine metabolite